For information about the PRX-03140 Phase 2a data, please call 866-514-2901.

July 2, 2008
EPIX Pharmaceuticals to Present at the Collins Stewart Fourth Annual Growth Conference

July 1, 2008
EPIX Pharmaceuticals Announces Resubmission of New Drug Application for Vasovist(R)

June 19, 2008
EPIX Pharmaceuticals to Present at the Eighth Annual Structure-Based Drug Design Conference